TABLE 3.
Group | Strain | n | Slope (SE) | LC50 (mg of AI/liter) | 95% FL | RR | D |
---|---|---|---|---|---|---|---|
Neonate | G88 (S) | 300 | 1.05 (0.15) | 0.339 | 0.166–0.578 | 1.0 | |
Cry1C-Sel (R) | 300 | 0.89 (0.10) | 4,200 | 2,270–7,760 | 12,400 | ||
S(f) × R | 300 | 1.10 (0.16) | 12.0 | 7.09–19.0 | 35.4 | −0.24 | |
R(f) × S | 300 | 1.18 (0.18) | 15.2 | 6.72–29.9 | 44.8 | −0.19 | |
Pooled F1 | 600 | 1.13 (0.12) | 13.6 | 6.88–23.8 | 40.1 | −0.22 | |
Second instar | G88 (S) | 150 | 1.90 (0.33) | 0.108 | 0.068–0.156 | 1.0 | |
Cry1C-Sel (R) | 150 | 2.22 (0.35) | 6,820 | 4,920–8,780 | 63,100 | ||
S(f) × R | 150 | 1.20 (0.18) | 5.78 | 3.72–9.65 | 53.5 | −0.28 | |
R(f) × S | 150 | 1.70 (0.30) | 8.20 | 4.69–12.4 | 75.9 | −0.22 | |
Pooled F1 | 300 | 1.49 (0.22) | 7.08 | 4.69–9.80 | 65.6 | −0.24 |